Trials / Conditions / Stage IA Breast Cancer AJCC v7

Stage IA Breast Cancer AJCC v7

22 registered clinical trials studyying Stage IA Breast Cancer AJCC v7 — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence NCT04054557	Thomas Jefferson University	N/A
Completed	SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer NCT03411070	Jonsson Comprehensive Cancer Center	EARLY_Phase 1
Completed	Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors NCT03407716	Mayo Clinic	EARLY_Phase 1
Active Not Recruiting	Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery NCT03317405	National Cancer Institute (NCI)	Phase 1
Completed	The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer NCT03454529	Michael Simon	Phase 2
Completed	Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery NCT03324802	Mayo Clinic	Phase 3
Completed	Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors NCT03319342	Jonsson Comprehensive Cancer Center	N/A
Suspended	Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer NCT03077841	M.D. Anderson Cancer Center	Phase 2 / Phase 3
Active Not Recruiting	Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer NCT02912312	M.D. Anderson Cancer Center	Phase 2
Recruiting	Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuva NCT02945579	M.D. Anderson Cancer Center	N/A
Completed	Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen P NCT02598557	National Cancer Institute (NCI)	Phase 2
Completed	Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC NCT02593175	M.D. Anderson Cancer Center	Phase 2
Completed	Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Tr NCT02689427	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment NCT02754752	M.D. Anderson Cancer Center	Phase 2
Completed	Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Sur NCT02654119	University of Nebraska	Phase 2
Active Not Recruiting	Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer NCT02276443	M.D. Anderson Cancer Center	N/A
Completed	Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer NCT03568526	Ohio State University Comprehensive Cancer Center	N/A
Completed	Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer NCT01275677	National Cancer Institute (NCI)	Phase 3
Active Not Recruiting	Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carci NCT01266642	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer NCT01245712	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node NCT00310180	National Cancer Institute (NCI)	Phase 3
Completed	Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With NCT00005970	National Cancer Institute (NCI)	Phase 3